Health Catalyst, Inc.
HCAT
$3.80
-$0.185-4.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.85% | -40.38% | -8.95% | 34.35% | 32.08% |
| Total Depreciation and Amortization | 21.30% | 3.78% | -10.46% | 2.86% | -0.96% |
| Total Amortization of Deferred Charges | 11.69% | -3.69% | 42.50% | -3.56% | 12.10% |
| Total Other Non-Cash Items | -12.41% | 25.99% | -24.01% | -33.61% | 15.25% |
| Change in Net Operating Assets | 175.45% | -238.86% | 145.08% | -194.99% | 148.07% |
| Cash from Operations | 107.94% | -156.81% | 285.11% | -84.30% | 153.92% |
| Capital Expenditure | -62.23% | 41.42% | -143.10% | -39.42% | 18.43% |
| Sale of Property, Plant, and Equipment | 133.33% | 0.00% | -25.00% | 33.33% | -70.00% |
| Cash Acquisitions | -61.97% | 29.93% | -94.17% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 259.34% | -295.05% | 159.75% | -79.61% | 102.60% |
| Cash from Investing | 185.82% | -1,574.61% | 528.83% | -102.12% | 180.72% |
| Total Debt Issued | -- | -68.13% | -- | -- | -- |
| Total Debt Repaid | -30.03% | 51.55% | -- | -- | -- |
| Issuance of Common Stock | 98.57% | -47.68% | -4.15% | -19.12% | 118.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 128.27% | -- | -- | -- |
| Cash from Financing | -112.50% | -66.50% | 16,016.76% | -19.12% | 118.48% |
| Foreign Exchange rate Adjustments | 92.71% | -215.66% | 4,250.00% | 89.47% | -155.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 217.34% | -162.23% | 23,982.29% | -99.45% | 741.17% |